Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer
H. Kurokawa,
C. L. Arteaga
Simmons Comprehensive Cancer Center - Administration - Directors Office - Administration
Simmons Comprehensive Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
99
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Estrogen Receptor Modulators
100%
ErbB Receptors
74%
Estrogen Receptors
72%
Protein-Tyrosine Kinases
70%
Breast Neoplasms
49%
Co-Repressor Proteins
45%
Tamoxifen
37%
Gefitinib
17%
Mitogen-Activated Protein Kinase 3
16%
Mitogen-Activated Protein Kinase 1
15%
Mitogens
14%
Mitogen-Activated Protein Kinases
14%
Nude Mice
13%
Protein Kinases
13%
Furylfuramide
11%
Receptor Cross-Talk
11%
Phosphotransferases
10%
RTKI cpd
10%
ErbB-2 Receptor
10%
Ligands
9%
Hormones
9%
Histone Acetyltransferases
9%
IGF Type 1 Receptor
8%
Second Messenger Systems
7%
Response Elements
7%
Phosphatidylinositol 3-Kinase
7%
Cyclic AMP
6%
Heterografts
6%
Dopamine
5%
Estrogens
5%
Cell Proliferation
4%
Growth
3%
Genes
2%
Therapeutics
2%
Neoplasms
2%